Literature DB >> 26555973

Self-Microemulsifying Drug Delivery System: Formulation and Study Intestinal Permeability of Ibuprofen in Rats.

Bharat Bhushan Subudhi1, Surjyanarayan Mandal2.   

Abstract

The study was aimed at developing a self-microemulsifying drug delivery system (SMEDDS) of Ibuprofen for investigating its intestinal transport behavior using the single-pass intestinal perfusion (SPIP) method in rat. Methods. Ibuprofen loaded SMEDDS (ISMEDDS) was developed and was characterized. The permeability behavior of Ibuprofen over three different concentrations (20, 30, and 40 µg/mL) was studied in each isolated region of rat intestine by SPIP method at a flow rate of 0.2 mL/min. The human intestinal permeability was predicted using the Lawrence compartment absorption and transit (CAT) model since effective permeability coefficients (P eff) values for rat are highly correlated with those of human, and comparative intestinal permeability of Ibuprofen was carried out with plain drug suspension (PDS) and marketed formulation (MF). Results. The developed ISMEDDS was stable, emulsified upon mild agitation with 44.4 nm ± 2.13 and 98.86% ± 1.21 as globule size and drug content, respectively. Higher P eff in colon with no significant P eff difference in jejunum, duodenum, and ileum was observed. The estimated human absorption of Ibuprofen for the SMEDDS was higher than that for PDS and MF (P < 0.01). Conclusion. Developed ISMEDDS would possibly be advantageous in terms of minimized side effect, increased bioavailability, and hence the patient compliance.

Entities:  

Year:  2013        PMID: 26555973      PMCID: PMC4590805          DOI: 10.1155/2013/328769

Source DB:  PubMed          Journal:  J Pharm (Cairo)        ISSN: 2090-9918


  18 in total

1.  Theoretical considerations on the in vivo intestinal permeability determination by means of the single pass and recirculating techniques.

Authors:  M Grassi; G Cadelli
Journal:  Int J Pharm       Date:  2001-10-23       Impact factor: 5.875

2.  Effect of self-microemulsifying drug delivery systems containing Labrasol on tight junctions in Caco-2 cells.

Authors:  Xianyi Sha; Guijun Yan; Yunjuan Wu; Junchan Li; Xiaoling Fang
Journal:  Eur J Pharm Sci       Date:  2005-04       Impact factor: 4.384

3.  [Absorption of zedoary oil in rat intestine using in situ single pass perfusion model].

Authors:  Jian You; Qing-po Li; Ying-wei Yu; Fu-de Cui
Journal:  Yao Xue Xue Bao       Date:  2004-10

4.  Enhanced bioavailability of silymarin by self-microemulsifying drug delivery system.

Authors:  Wei Wu; Yang Wang; Li Que
Journal:  Eur J Pharm Biopharm       Date:  2006-03-09       Impact factor: 5.571

5.  Self-emulsifying drug delivery systems (SEDDS) of coenzyme Q10: formulation development and bioavailability assessment.

Authors:  T R Kommuru; B Gurley; M A Khan; I K Reddy
Journal:  Int J Pharm       Date:  2001-01-16       Impact factor: 5.875

6.  Evaluation of a single-pass intestinal-perfusion method in rat for the prediction of absorption in man.

Authors:  L Salphati; K Childers; L Pan; K Tsutsui; L Takahashi
Journal:  J Pharm Pharmacol       Date:  2001-07       Impact factor: 3.765

7.  Processing factors in development of solid solution formulation of itraconazole for enhancement of drug dissolution and bioavailability.

Authors:  S G Kapsi; J W Ayres
Journal:  Int J Pharm       Date:  2001-10-23       Impact factor: 5.875

8.  Mechanism of colonic permeation of inulin: is rat colon more permeable than small intestine?

Authors:  T Y Ma; D Hollander; R A Erickson; H Truong; H Nguyen; P Krugliak
Journal:  Gastroenterology       Date:  1995-01       Impact factor: 22.682

9.  Oral bioavailability enhancement of acyclovir by self-microemulsifying drug delivery systems (SMEDDS).

Authors:  Deepa Patel; Krutika K Sawant
Journal:  Drug Dev Ind Pharm       Date:  2007-12       Impact factor: 3.225

10.  Design and evaluation of microemulsions for improved parenteral delivery of propofol.

Authors:  Abhijit A Date; Mangal S Nagarsenker
Journal:  AAPS PharmSciTech       Date:  2008-01-19       Impact factor: 3.246

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.